1-6 of 6
Dawn Swan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1b study of cyclophosphamide, pomalidomide, dexamethasone, and daratumumab (CPD-DARA) in relapsed/refractory multiple myeloma: Safety and efficacy in a heavily pretreated population

Free
Janusz Krawczyk, Dawn Swan, John Quinn, Vitaliy Mykytiv, Mary R Cahill, Siobhan Glavey, Amjad Hayat, Yizel Paz Nunez, Derville O'Shea, Shahed Abdullah, Anna Dyszkiewicz, Shikha Bakshi, Katherine Cussen, Keith Egan, Michelle Hennessy, Dorota Matczuk, Laura Sheehan, Angela Clayton-Lea, Olivia McLoughlin, Jacinta Marron, Vicky Donachie, Marc Nolan, Fiona Cregg, Sylva Helanova, Isabel Beristain, Matthew Kiely, Rachel O'Rourke, Shannon Gallagher, Arjun Nataraj, Aideen Ryan, Michael O'Dwyer
Journal: Blood
Blood (2025) 146 (Supplement 1): 4031.
https://doi.org/10.1182/blood-2025-4031
Published: 2025
Journal Articles

Toxicity Outcomes in Phase 1 Lymphoma Trials: Variable Reporting with High Use of Minimising Language in Published Abstracts at International Conferences

Free
Marsali Maclean, Niamh Waters, Charmaine Smith, Darcy Vickers, Dawn Swan, Arina Martynchyk, Denise Lee, Geoffrey Chong, Eliza A. Hawkes
Journal: Blood
Blood (2024) 144 (Supplement 1): 2267.
https://doi.org/10.1182/blood-2024-198377
Published: 2024
Journal Articles

Toxicity Outcomes in Phase 1 Interventional Studies in Plasma Cell Dyscrasias: Heterogeneous Reporting and High Usage of Minimising Language

Free
Dawn Swan, Marsali Maclean, Niamh Waters, Denise Lee, Charmaine Smith, Arina Martynchyk, Eliza A. Hawkes, Jay Hocking
Journal: Blood
Blood (2024) 144 (Supplement 1): 5139.
https://doi.org/10.1182/blood-2024-193867
Published: 2024
Journal Articles

Cybord-Dara in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Follow up Results from the 16-Bcni-001/Ctrial-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment

Free
Dawn Swan, Michael E. O'Dwyer, Mary Cahill, Janusz Krawczyk, Vitaliy Mykytiv, John Quinn, Robert Henderson, Cian McEllistrim, Andres Hernando, Imelda Parker, Marc Nolan, Elizabeth Lenihan, Eva Szegezdi, Serika D Naicker, Kevin Lynch, Alessandro Natoni, Aideen Ryan, Philip Murphy
Journal: Blood
Blood (2021) 138 (Supplement 1): 2756.
https://doi.org/10.1182/blood-2021-145530
Published: 2021
Journal Articles

Hypersialylation Protects Multiple Myeloma Cells from NK Cell-Mediated Immunosurveillance and This Can be Overcome By Targeted Desialylation Using a Sialyltransferase Inhibitor

Free
John Daly, MSc, Subhashis Sarkar, PhD, Alessandro Natoni, PhD, Robert Henderson, MB BCh, Dawn Swan, Mattias Carlsten, MD PhD, Michael E O'Dwyer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 138.
https://doi.org/10.1182/blood-2019-126613
Published: 2019
Journal Articles

Platelets Preferentially Bind to Myeloma Cells Bearing Sialofucosylated Structures and Protect Them from Natural Killer Cell-Mediated Cytotoxicity

Free
Robert Henderson, MB BCh, Lucy Kirkham-McCarthy, MSc, Dawn Swan, BM BCh, Michael E O'Dwyer, MD, Alessandro Natoni, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2018-99-116747
Published: 2018